In addition, the CD38 promoter peak overlapped with IRF4 peaks in published chromatin immunoprecipitation with sequencing (ChIP-seq) data for the MM cell line KMS12BM20 (Fig. 4d), suggesting a link between increased IRF4 activity and overexpression of CD38. This evidence concerns the gene IRF4 and Miyoshi myopathy.